Cipher Pharmaceuticals Inc.
CPHRF
$8.95
$0.303.47%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 14.00% | 95.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.00% | 95.51% | |||
| Cost of Revenue | 160.36% | 78.12% | |||
| Gross Profit | -20.32% | 100.10% | |||
| SG&A Expenses | 5.28% | 249.66% | |||
| Depreciation & Amortization | -21.51% | 559.25% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 35.15% | 213.08% | |||
| Operating Income | -82.14% | -27.77% | |||
| Income Before Tax | -975.46% | -87.04% | |||
| Income Tax Expenses | -14,513.95% | 108.96% | |||
| Earnings from Continuing Operations | 1,081.63% | -90.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1,081.63% | -90.55% | |||
| EBIT | -82.14% | -27.77% | |||
| EBITDA | -55.97% | 31.73% | |||
| EPS Basic | 1,060.71% | -90.98% | |||
| Normalized Basic EPS | -202.97% | -34.90% | |||
| EPS Diluted | 1,200.00% | -91.67% | |||
| Normalized Diluted EPS | -204.97% | -34.97% | |||
| Average Basic Shares Outstanding | 2.19% | 4.39% | |||
| Average Diluted Shares Outstanding | 0.11% | 4.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||